register

News & Trends - MedTech & Diagnostics

ESG momentum accelerates as medtech companies champion APAC initiative

Health Industry Hub | October 4, 2023 |

MedTech & Diagnostics News: Environmental, Social, and Governance (ESG) regulations are accelerating across the Asia Pacific (APAC) region. It is now an impending reality that all corporates and asset managers must face, confronting new material cost considerations, an urgent need for up-skilling and potential valuation implications for stocks.

APACMed, the industry association for the medtech sector in the APAC region, has joined forces to place ESG at the forefront of strategic priorities. To comprehensively understand the challenges faced by key stakeholders in navigating the ESG landscape, the organisation brought together nominated representatives from 15 member companies, including Abbott, BBraun, Boston Scientific, Cardinal Health, Fresenius Medical Care, Johnson and Johnson, Karl Storz, Medtronic, Olympus, Roche Diagnostics, Siemens Healthineers, Steris, Stryker, Teleflex, and Thermo Fisher Scientific.

As a first step, the initiative introduced a dashboard providing a view of evolving ESG regulations in six key APAC markets, including Australia, China, India, Japan, South Korea, and Vietnam. To gain stakeholder insights, a survey was conducted among personnel from large hospitals and healthcare groups across the six APAC markets. Additionally, employee perspectives were gathered through surveys and one-on-one interviews encompassing various functions within member companies.

In understanding the relevant ESG themes within the APAC region, research from Goldman Sachs highlighted significant aspects that are relevant to this region.

APAC’s ESG policy development, mirroring the strides in Europe, has led to improved corporate disclosure. Over the past five years, APAC ESG policies have doubled, now constituting 20% of global ESG policy, significantly closing the gap with Western Europe (44%) and surpassing North America (4%). These policies are addressing crucial aspects such as climate/carbon, supply chain, and ESG disclosures, in line with European trends.

Significant shifts are expected, particularly in asset management decisions, with carbon likely to represent an increasing weightage. Emerging ESG fund requirements across various APAC countries necessitate asset managers to disclose the integration of ESG into the investment process, potentially widening valuation premiums for low carbon emitters.

Already, established carbon pricing schemes are in place in mainland China, Japan, New Zealand, South Korea, and Singapore, albeit with varying applications and scopes. The outlook predicts a tightening of these schemes in the medium term, aligning with national net zero targets.

Looking ahead, global ESG standards are anticipated to be launched this year by the International Sustainability Standards Board (ISSB), promising improved corporate disclosure across the region. As investors gain access to more ESG data, the focus should shift towards measuring actual performance, emphasising the clear links between ESG metrics and return on capital.

However, APAC corporates are faced with the challenge of being unprepared for impending international supply chain due diligence demands. Given the region’s unique position as a global supply chain hub and the current lack of robust supply chain-related policies, APAC corporates face significant challenges in compliance.

Unlike Europe, APAC countries lack a centralised regulatory body to implement and enforce ESG policies, potentially resulting in unharmonised standards and varied adoption timelines. This raises concerns regarding compliance and creates challenges in assessing the full impact of incoming ESG regulations on APAC capital markets.

The insights and learnings from the APACMed initiative will culminate in a comprehensive report, slated for release at the end of October 2023. This report will not only present findings but also offer strategic recommendations for the medtech industry on how to navigate the evolving ESG landscape in the APAC region.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Federal Health Minister meets with private hospital leaders to tackle sector reforms

Federal Health Minister meets with private hospital leaders to tackle sector reforms

Health Industry Hub | June 20, 2024 |

MedTech & Diagnostics News: In the past five years, 71 private hospital services have closed down as a result of […]

More


News & Trends - Pharmaceuticals

Medicines Australia warns against panic buying or stockpiling of drugs facing supply shortages

Medicines Australia warns against panic buying or stockpiling of drugs facing supply shortages

Health Industry Hub | June 20, 2024 |

Pharma News: Over 400 medicines are currently facing shortages nationwide, according to the Therapeutic Goods Administration (TGA). Among these, 39 […]

More


News & Trends - MedTech & Diagnostics

HCF partners with clinicians to optimise colonoscopy procedures in public hospitals

HCF partners with clinicians to optimise colonoscopy procedures in public hospitals

Health Industry Hub | June 20, 2024 |

MedTech & Diagnostics News: As Australia marks Bowel Cancer Awareness Month this June, the HCF Research Foundation highlights its support […]

More


Digital & Innovation

Australian AI-powered tool promises rapid stroke detection

Australian AI-powered tool promises rapid stroke detection

Health Industry Hub | June 20, 2024 |

Digital & Innovation: An Australian innovation promises to transform stroke care by enabling quicker intervention and improving patient outcomes through […]

More


This content is copyright protected. Please subscribe to gain access.